ReCor Medical
Lara Barghout is currently the President & Chief Executive Officer at Recor Medical. Prior to that, Lara held the position of Senior Vice President - Head of Advanced Therapies NAM at Siemens Healthineers. With over two decades of experience, Lara also served as Senior Vice President at Terumo Cardiovascular, where Lara led various global commercial operations. Lara holds a Master of Business Administration from the University of Michigan - Stephen M. Ross School of Business and a Bachelor's Degree from Jordan University of Science and Technology.
ReCor Medical
ReCor Medical has developed a unique therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The PARADISE® technology (Percutaneous Renal Denervation System) includes a 6 French catheter with a cylindrical transducer that emits ultrasound energy circumferentially, allowing for a moreefficient renal denervation procedure.